Alpha 2.0
Login Register
» Articles » PMID: 38164513

Editorial: Current Trends and Future Perspectives About Liquid Biopsy

Overview
Journal Front Genet
Date 2024 Jan 2
PMID 38164513
Authors
Elisa Frullanti
Maria Jose Serrano
Affiliations
Soon will be listed here.
Citing Articles

Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC.

Bafiti V, Thanou E, Ouzounis S, Kotsakis A, Georgoulias V, Lianidou E Cancers (Basel). 2024; 16(22).

PMID: 39594687 PMC: 11592109. DOI: 10.3390/cancers16223729.

References
1.
Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View
2.
Liu L, Lin F, Ma X, Chen Z, Yu J . Tumor-educated platelet as liquid biopsy in lung cancer patients. Crit Rev Oncol Hematol. 2020; 146:102863. DOI: 10.1016/j.critrevonc.2020.102863. View
3.
Gaforio J, Serrano M, Sanchez-Rovira P, Sirvent A, Delgado-Rodriguez M, Campos M . Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer. 2003; 107(6):984-90. DOI: 10.1002/ijc.11479. View
4.
Mehran R, Nilsson M, Khajavi M, Du Z, Cascone T, Wu H . Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy. Cancer Res. 2014; 74(10):2731-41. PMC: 4024326. DOI: 10.1158/0008-5472.CAN-13-2044. View
5.
Yu W, Hurley J, Roberts D, Chakrabortty S, Enderle D, Noerholm M . Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021; 32(4):466-477. PMC: 8268076. DOI: 10.1016/j.annonc.2021.01.074. View